Axicabtagene Ciloleucel (axi-cel; KTE-C19) in Patients with Refractory Aggressive Non-Hodgkin Lymphoma (NHL): Long-Term Follow-up of the Pivotal Zuma-1 Trial

作者:Neelapu Sattva S.; Locke Frederick L.; Bartlett Nancy L.; Lekakis Lazaros J.; Miklos David; Jacobsen Eric; Braunschweig Ira; Oluwole Olalekan; Siddiqi Tanya; Lin Yi; Timmerman John; Reagan Patrick; Bot Adrian; Rossi John; Navale Lynn; Jiang Yizhou; Aycock Jeff; Elias Meg; Wiezorek Jeff; Go William Y.
来源:Blood and Marrow Transplantation Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT), 2018-02-21 to 2018-02-25.
  • 出版日期2018-3